Background/Aims: L-arginine is an important mediator of cell division, wound healing, and immune function. It can be transformed by the nitric oxide synthase (NOS) to nitric oxide (NO), an important cell signaling molecule. Recent studies from our laboratory demonstrate specific effects of L-arginine (10mM) exposure on gastric acid secretion in rat parietal cells. Methods: Studies were performed with isolated gastric glands and the pH sensitive dye BCECF-AM +/-L-arginine to examine its effects on acid secretion. The direct NO-donor diethylamine NONOate sodium salt hydrate, was also used while monitoring intracellular pH. The specific inhibitor of the intracellular NO signal cascade ODQ was also used. Results: We found that gastric proton extrusion was activated with application of L-arginine (10mM), in a separate series when L-arginine (10mM) + L-NAME (30µM) were added there was no acid secretion. Addition of the NO-donor diethylamine NONOate sodium salt hydrate (10µM) also induced acid secretion. When the selective sGC-inhibitor ODQ was added with NONOate we did not observe acid secretion. Conclusion: We conclude that L-arginine is a novel secretagogue, which can mediate gastric acid secretion. Furthermore, the intake of L-arginine causes direct activation of the H + , K + ATPase and increased proton extrusion from parietal cells resulting in the increased risk for acid-related diseases. The NO/sGC/cGMP pathway has never been described as a possible intracellular mechanism for H + , K + ATPase activation before and presents a completely new scientific finding. Moreover, our studies demonstrate a novel role for L-NAME to effectively eliminate NOS induced acid secretion and thereby reducing the risk for L-arginine inducible ulcer disease.
Introduction
L-arginine belongs to the semi-essential amino acids [1] and is the sole endogenous nitrogen carrying substrate for endothelial nitric oxide (NO) synthesis by the nitric oxide synthase (NOS) [2] [3] [4] . Next to NO synthesis, L-arginine serves as the substrate for the enzymatic transformation of agmatine, creatine and urea in the human body [4, 5] . As the only precursor and nitrogen donor for nitric oxide (NO), L-arginine plays a central role in the form of a messenger in several physiological and pathophysiological processes [6] [7] [8] [9] . Thus, L-arginine can be considered as a signaling molecule, which is responsible for the maintenance of essential cellular functions e.g. protein synthesis, cell death and growth [4, 10, 11] . As a semi-essential amino acid, L-arginine can be provided by an endogenous and an exogenous source. The kidney can subsist a basal L-arginine de-novo synthesis [4, 12] , but especially during a high L-arginine demand, like growth, inflammation or wound healing processes, L-arginine-rich food intake is pivotal for the sustain of an adequate supply [4, 13, 14] . Hence, a dietary intake of L-arginine of 1-3g/d through food is recommended [4, 15] . The import of the hydrophobic amino acid through biological membranes occurs through a variety of transportation systems within the lipid bilayer. The arginine uptake in the parietal cell of the gastric gland can be Na + -independent or Na + -dependent. The cationic amino acid transporter (CAT), the hetero(di)meric amino acid transporter (HAT) and the peptide transporter (PEPT) are responsible for the intracellular uptake of L-arginine. The isoforms of the CAT have a broad expression and are ubiquitously represented [16, 17] . They work Na + -independent and equally transport other amino acids into the cell, e.g. ornithine and lysine [18] . HATs, especially the isoform rBAT/b 0, + , are responsible for a transepithelial cationic amino acid exchange between cells and PEPT1 and PEPT2 are H + dependent transporters of di-and tripeptides [19, 20] . Once L-arginine resides in the cell, the NOS converts it into NO and the byproduct L-citrulline [21] . Different types of NOS exist, which vary in distinct location and function: eNOS (NOS-3, endothelial), nNOS (NOS-1, neuronal) and iNOS (NOS-2, inducible) [22, 23] . Evidence about a mitochondrial NOS have been reported, but scientists couldn´t identify structure and function to date [23, 24] . The endothelial nitric oxide synthase (eNOS) is responsible for the regulation of blood pressure and angiogenesis through intracellular signaling transductions [22, 25, 26] whereas the neuronal NOS (nNOS) is involved in neurotransmission, learning processes and synaptic plasticity [3, 25] . The isoforms eNOS and nNOS are acting via a calcium dependent pathway and regulate neuronal, and vascular processes through calmodulin binding [23] . The third isoform of the NOS system, the inducible NOS (iNOS) plays an important role in innate immune responses and antipathogenic processes during infections with viruses and bacteria [25, 27, 28] , and modulates tumor development [22, 25, 28] . The iNOS system is calcium-independent and produces high amounts of gas and radicals respectively, forming a cytotoxic microenvironment within the cell, which can be found during infection and tumor development [7] . NO is considered as one of the most important intracellular signaling molecules [21] . It is responsible for blood flow regulation and leads to vasodilatation [7, 23, 29] and inhibition of platelets aggregation [23, 30] . Besides, NO is a crucial trigger for cardiac development during embryogenesis [31] . Activation of the intracellular receptor NO-GC through NO leads to an increase of soluble guanylyl cyclase (sGC) and further to accumulation of cyclic guanosine monophosphate (cGMP) [31, 32] . We hypothesize, that L-arginine stimulated gastric acid secretion in parietal cells occurs through the NO/NO-GC/cGMP signaling pathway and can increase the risk for all acid-related diseases such as peptic ulcer disease (GUD), non-erosive reflux disease (NERD), gastroesophageal reflux disease (GERD) to the point of the development of gastric and esophageal malignancies. Thus, L-arginine can be considered as a potential causative agent for these gastrointestinal diseases and excessive L-arginine intake can lead to severe disadvantages for the stomach. Other, well-known causes are non-steroidal anti-inflammatory drugs (NSAIDs), nicotine, alcohol, caffeine, stress and infections [33] [34] [35] [36] . Since the prevalence of gastroesophageal Cellular Physiology and Biochemistry
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ailments is continuously increasing in the United States [37] , new findings about causative agents are of highly interest. The present study focuses on intracellular changes of pH recovery rate following L-arginine application and provides detailed information about the mechanism and intracellular characteristics of the L-arginine induced gastric acid secretion. We have chosen L-NAME as a non-selective NOS inhibitor and were able to prevent gastric secretion by inhibiting the L-arginine stimulated NO/NO-GC/cGMP signaling pathway in the parietal cell.
Materials and Methods

Animals and preparation of the stomach
We used male Sprague-Dawley rats with a weight of 250-400g (Charles River Laboratory), housed in climate and humidity controlled light-cycled rooms, fed standard chow with ad lib access to water 24h. Animals were handled according to the humane practices of Animal Care established by the Institutional Animal Care and Use Committee at Yale University. Animals were food deprived for 12-16h with ad lib access to water before being euthanized with an overdose of isoflurane. We performed a laparotomy, removed the stomach and separated the corpus of the stomach with a longitudinal incision. After the isolation of the corpus, it was washed with ice-cold HEPES buffered Ringer solution to remove residual food particles and was sliced it into 0.2cm square tissue sections. The procedure, including gastrectomy was executed quickly and small tissue sections were kept on ice in a petri dish filled with ice-cold HEPES buffered Ringer solution to guarantee vitality and cell function of the gastric glands [38] .
Hand-dissection and isolation of gastric glands
Single sections of the corpus were transferred to the stage of a dissecting microscope and isolation of individual glands was carried out with the hand-dissection technique as described previously [39, 40] . Briefly, the corpus was cut into 2cmx2cm squares and then each square was further cut into single 1cmx1cm sections. The muscle layer was dissected off the section in a bath of ice cold Ringer buffer solution at 4 o C. Individual gastric glands were dissected from these sections and then transferred in cold Ringer solution to the perfusion chamber. Gastric glands were allowed to adhere to coverslips coated with 0.5µl of the biological adhesive Corning CellTak (Collaborative Research, MA, USA), a widely-used and well known polyphenolic protein-based tissue adhesive, that can strongly bind inorganic as well as organic surfaces in hydrous environment [41] . Accordingly, coverslips were attached to a perfusion chamber as previously outlined [37, 39] . A minimum of 4-6 glands were transferred to the coated coverslips prior to dye loading.
Digital Imaging for intracellular pH measurements
The isolated gastric glands were incubated in a room tempered HEPES-buffered Ringer´s solution containing 10µM of the pH-sensitive dye BCECF-AM(2´,7´)-bis-(2-carboxyethyl)-5-(and-6)-carboxyflourescin-acetomethylester (Santa Cruz Biotechnology, TX, USA) for 20min. Following dye incubation, the perfusion chamber was placed on the stage of an inverted microscope (Olympus IX50) and flushed with a HEPES-buffered Ringer´s solution for 5 minutes to remove residual non-de-esterified dye. During this flushing phase, the temperature of the chamber and the perfusate were raised to 37 o C. The chamber was thermostatically controlled and maintained for the remainder of the study at 37°C. The epifluorescence mode with an x40 objective was used and the BCECF loaded gland was excited at the wavelengths of 490nm ± 10nm and 440nm ± 10nm. A minimum of 8 regions of interest were outlined per gland and simultaneously monitored during the whole experimental procedure. The resultant fluorescent signals of BCECF were successfully monitored at a wavelength of 530nm ± 10nm every 10sec with the help of an intensified chargecoupled device camera. Individual images and intensity values were recorded along with the emission data showing the 490/440 ratio for real-time intensity measurements [37] . At the end of each experimental cycle, cells were calibrated with the High K + /nigericin calibration technique to convert all ratiometric data and calculate the intracellular pH from the emission data as described in previous studies [42] .
The recovery of intracellular pH (pH i ) from an acid load demonstrates the rate of proton extrusion by individual parietal cells after acid/proton loading using the NH 4 Cl prepulse technique [39] . Therefore, the cells were superfused with a HEPES-buffered solution containing 40mM NH 4 Cl to load the cells with Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry hydrogen ions. Parietal cells were subsequently flushed with Na + free solution to eliminate activation the Na-H-Exchanger (NHE) and trapping protons within the cytosol causing a strong drop of pH i . Cells were then flushed with HEPES and finally with the HighK + calibration solution to clamp intracellular pH to 7.0. Recovery rates were expressed in dpH i /dT (DpH/min) for all studies following the conversion of the ratio data using the Henderson-Hasselbach Equation as previously described [43, 44] . The observed recovery rate of intracellular pH (pH i ) represents proton extrusion by the parietal cells. Intracellular pH i recovery rates were calculated from the same initial starting pH to eliminate variation in individual intracellular buffering power of the cells under different experimental conditions. Recovery rates are expressed in DpH/min.
Chemicals and reagents
Temperature and pH of all solutions (see Table 1 ) were adjusted to 37°C and 7.4, with the exception of High K + calibration solution, which was titrated to 7.0. The final osmolality of all solutions was 300mOsm. All chemicals, including L-arginine, L-NAME (NG-nitro-l-arginine methyl ester), Carbachol, ODQ (1H- 
Statistical analysis
Graphpad/ Prism 7.0 software was used to analyze differences in pH i recovery rates. We performed the unpaired, parametric Student´s t-tests to exemplify significant differences in pH i recovery rates. DpH/min values are presented as mean ± SEM. All results with p < 0.05 were considered to be significant.
Results
To examine the rapid cellular effect of L-arginine on acid secretion, studies were performed using the isolated gastric gland preparation. In the absence of any stimulation (Control), a low-basal rate of pH i recovery was observed (0.0003711 ± 0.0006969 ΔpHi/min).
In the first series of experiments, gastric glands superfused with L-arginine (10mM) containing solutions were able to induce secretory stimulation resulting in an elevation of the pH i recovery rate (0.02999 ± 0.002718 DpH/min) (Fig.1) .
A highly significant difference in proton extrusion can be noticed in L-arginine experiments compared to control conditions (p < 0.0001). Bar graph summarizes the effect of L-arginine 10mM on resting parietal cells (0.02999 ± 0.002718 pH/min) (n=146). Isolated gastric glands of rats were loaded with the pH sensitive dye BCECF and excited at 490nm ± 10nm and 440nm ± 10nm. The recovery rate of pH i was calculated from the slope in the absence of Na + after acid loading, using the NH 4 Cl prepulse technique [39] . The control shows a low basal proton efflux of the resting parietal cell in the absence of stimulatory agents (0.0003711 ± 0.0006969 ΔpHi/min) (n=66). In a separate series of experiments, we used solutions that contained a combination of L-NAME (30µM) and L-arginine (10mM). Our results show that we can achieve a significant decrease in L-arginine induced gastric acid secretion in the presence of the non-selective NOS inhibitor L-NAME compared to L-arginine dependent gastric acid secretion in the absence of L-NAME (0.002185 ± 0.0004337 DpH/min vs. 0.02999 ± 0.002718DpH/min, p < 0.0001) (Fig.  2) .
In another set of experiments, we induced a stimulatory effect of proton extrusion with the classical secretagogue carbachol (200µM) and obtained a pH i recovery rate of 0.03291 ± 0.002645 DpH/min. To see, if the proton extrusion by carbachol is sensitive to L-NAME, we added L-NAME (30µM) to the carbachol containing solutions. The carbachol sensitive proton extrusion was not inhibited by L-NAME and recovery rates did not show a significant difference in pH i compared to carbachol dependent gastric acid secretion in the absence of L-NAME (0.03291 ± 0.0026450 DpH/min vs. 0.03362 ± 0.0040260 DpH/min, p=ns) (Fig. 3) .
We compared the pH i recovery rates of L-NAME (30µM) + L-arginine (10mM) to L-NAME (30µM) + carbachol (200µM), demonstrating a highly significant difference in gastric acid secretion (0.002185 ± 0.0004337 vs. 0.03362 ± 0.0040260 DpH/min, p = 0.0001) (Fig. 4) In a final series of experiments, we verified our hypothesis, that L-arginine acts through the intracellular NO pathway in gastric glands. Therefore, we added the direct NO donor diethylamine NONOate sodium salt hydrate 10µM to our solutions [45] . The application of the NO donor resulted in increased H + extrusion from the parietal cell (0.03093 ± 0.002054 DpH/min). By adding the potent and selective inhibitor of nitric oxide sensitive guanylyl cyclase inhibitor ODQ (1H- [1, 2, 4] Oxadiazolo [4, 3-a]quinoxalin-1-one) (10µm) to our diethylamine NONOate sodium salt hydrate containing solutions, we were able to abolish the effect on H + , K + ATPases activation to a basal level (0.00009813 ± 0.0006929 DpH/min). Interestingly, we preserved nearly identical results for proton extrusion with a combination of ODQ (10µM) and L-arginine (10mM) containing solutions (0.001077 ± 0.00048 DpH/ min) (Fig. 5) .
Our results evidence, that observations are due to NO formation accordingly mediated Fig. 3 . Bar graph compares the effect of the classical secretagogue carbachol on rat gastric glands (0.03291 ± 0.0026450 DpH/min) (n=168) to a combination of carbachol and L-NAME together (0.03362 ± 0.0040260 DpH/ min) (n=104). Our results demonstrate, that carbachol-induced gastric acid secretion cannot be suppressed by the NOS inhibitor L-NAME. We conclude, that L-arginine and carbachol differ in their intracellular pathway leading to the assembly and final activation of the H + , K + ATPase. 
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by cGMP and sGC, as L-arginine induced gastric acid secretion can be inhibited by the cellpermeable and selective sGC-inhibitor ODQ leading to an effective inhibition of cyclic GMP production.
Discussion
Our results demonstrate that L-arginine is a potent NOS activator, which can induce acid secretion via the H + , K + ATPase activation in resting glands or can also work in activated glands via an independent pathway (Fig. 6) . Our data strongly suggest that increased levels of L-arginine in the blood following a meal can cause a continued secretion of acid from the parietal cell even in the absence of classical secretagogues, and the normal modulators of post secretagogue acid secretion (Fig.7) . When we conducted a separate series of studies in the presence of the non-selective NOS inhibitor L-NAME we could prevent the L-arginine induced acid secretion. This result suggests there is an additional feedback loop linked to the generation and degradation of NO in the gastric gland that modulates acid secretion in the absence of conventional secretagogues.
This study demonstrates the novel effect of L-arginine on gastric parietal cells, its potency as a secretagogue and influence on gastric acid secretion. Moreover, we highlight the relevance of NOS in the L-arginine dependent intracellular signaling pathway, as we can abolish L-arginine induced gastric acid secretion by the application of the non-selective NOS inhibitor L-NAME. We suggest eNOS to be the important mediator involved in this process due We applied the NO-donor diethylamine NONOate sodium hydrate (NONO) 10µM to our solution and results demonstrate the increase of gastric acid secretion (0.03093 ± 0.002054 DpH/min) (n=183). By adding the sGC-inhibitor ODQ to our NONOate containing solutions, we were able to abolish this effect completely to the level of basal proton efflux (0.00009813 ± 0.0006929 DpH/min) (n=140). In addition, we combined L-arginine containing solutions with ODQ and achieved a nearly similar effect (0.001077 ± 0.00048 DpH/min) (n=185). Thus, we prove that L-arginine stimulated gastric acid secretion is dependent on the intracellular NO/sGC pathway. Fig. 4 . Bar graph highlighting the difference between L-arginine and carbachol: L-arginine induced gastric acid secretion can be inhibited by L-NAME (0.002185 ± 0.0004337 DpH/min) (n=179), whereas stimulation of acid secretion by the classical secretagogue carbachol is not preventable by L-NAME application (0.03362 ± 0.0040260 DpH/min) (n=104). Thus, both agents differ in their intracellular pathway to induce secretion. Carbachol leads to an intracellular increase of cAMP levels using muscarinic receptors, which induces the insertion and activation of H 
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Cellular Physiology and Biochemistry to the selective activators and inhibitors that we have used for our study. Furthermore, based on our long experience using isolated gastric gland preparation and previous publications, we have never had any evidence that the dissected single gland has an active neuronal circuit. Studies by Price et al. have shown that the constitutive form of NOS is represented in the gastric mucosa [46] . The constitutive form is calcium/calmodulin dependent and implicates the endothelial (eNOS) and neuronal (nNOS) isoform [46] . The expression of nNOS in rat gastric parietal cells was confirmed by Premarante by NADPH-diaphorase histochemistry, nNOS immunostaining, Western blotting and RT-PCR and published in 2001 [47] . However, the technique used for this study differs from our: they used immunodissected glands whereas we used hand dissected glands. Expression of the isoforms change under pathological conditions, e.g. carcinogenesis or H. pylori infection of the stomach. The expression of the constitutive isoforms of NOS changed according to the stadiums of the malignancies and varied from reduction to an almost complete loss to an overexpression of the enzymes. Interestingly, iNOS was expressed in the tissue of cardia and fundus of the stomach, although it is not represented under physiological conditions [48] .
The link between gastric acid secretion and the NO/NO-GC/cGMP pathway is furthermore highlighted by our diethylamine NONOate sodium salt hydrate and the sGC inhibitor ODQ experiments. The application of the direct NO-donor diethylamine NONOate sodium salt hydrate increases gastric acid secretion and verifies our hypothesis that L-arginine induced gastric acid secretion is NO-derived. Experiments with the sGC inhibitor ODQ demonstrates its potency to inhibit gastric acid secretion induced by both, NONOate or L-arginine. Thus, ODQ could become potentially a new agent against acid-related gastrointestinal diseases. 
